The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Sen­a­tors tell FDA that ‘greater ac­tion is need­ed’ to use man­u­fac­tur­ing tech in US sup­ply chains

8 months ago
Pharma
FDA+

Ther­at­e­ch­nolo­gies' HIV drug to face sup­ply is­sues in 2025 over third-par­ty fa­cil­i­ty shut­down 

8 months ago
Pharma
FDA+

CD­MO Serán sets out to build first com­mer­cial fa­cil­i­ty, with a $200M in­vest­ment led by Bain Cap­i­tal

8 months ago
Pharma

Co­herus warns of lim­it­ed can­cer drug sup­ply due to third-par­ty ‘ca­pac­i­ty con­straints’

8 months ago
Pharma

Roche out­lines com­mer­cial man­u­fac­tur­ing strat­e­gy for GLP-1/GIP as­sets 

8 months ago
Pharma

WHO pre-qual­i­fies Bavar­i­an Nordic’s vac­cine as first mpox shot

8 months ago
Pharma

Aus­tralian RNA man­u­fac­tur­er launch­es; Forge Bi­o­log­ics’ CEO steps down

8 months ago

Charles Riv­er to lay off 3% of staffers as it stream­lines spend­ing

8 months ago
People

Lil­ly bud­gets $1.8B to boost Kisun­la, GLP-1 man­u­fac­tur­ing in Ire­land

8 months ago

FDA drafts new strat­e­gy to boost the use of ad­vanced man­u­fac­tur­ing tech

8 months ago
FDA+

Sanofi opens ‘world first’ mod­u­lar vac­cines and bi­o­log­ics fac­to­ry in France 

8 months ago

Pan­Tera rais­es €93M to ‘rad­i­cal­ly im­prove sup­ply’ of ac­tini­um for ra­dio­ther­a­peu­tics 

8 months ago
Financing

Con­gress spars over whether the Biose­cure Act is an over­due crack­down or a rushed witch hunt

8 months ago
China
FDA+

FDA sends warn­ing let­ter to In­di­an drug­mak­er af­ter find­ing glass in in­jec­tions 

8 months ago
FDA+

GSK to shut down UK an­tibi­ot­ic fa­cil­i­ty fol­low­ing end of San­doz con­tract

8 months ago
Pharma

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

8 months ago
China
Law

Astel­las to close fa­cil­i­ty in Cal­i­for­nia; Take­da can make more of its AD­HD drug

8 months ago

With $200M in­vest­ment, No­var­tis builds out ra­di­oli­gand man­u­fac­tur­ing at two sites

8 months ago
Pharma

No­vo Nordisk con­tin­ues to grap­ple with patchy GLP-1 drug sup­ply in Eu­rope

8 months ago
Pharma

Cor­rect­ed: Afrigen, CEPI to speed up mR­NA vac­cine man­u­fac­tur­ing; Bo­ra Phar­ma in­vests in Tan­vex

8 months ago

Ahead of ac­qui­si­tion by No­vo Hold­ings, are Catal­ent’s dark days be­hind it? 

8 months ago
Pharma

Sanofi paus­es sup­ply of two flu vac­cines in Chi­na over ‘un­ex­pect­ed cir­cum­stances’ 

9 months ago
China
Pharma

FDA warns Eye­Point over eye im­plant man­u­fac­tur­ing woes

9 months ago
FDA+

No­var­tis part­ners with small North Car­oli­na biotech to make its bi­o­log­ics more 'con­ve­nien­t'

9 months ago
Startups
Deals
First page Previous page 78910111213 Next page Last page
A service from the Financial Times